LIGAND PHARMACEUTICALS INCORPORATED Other Liabilities, Fair Value Disclosure
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) had Other Liabilities, Fair Value Disclosure of $71.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:OtherLiabilitiesFairValueDisclosure · last filed 2020-11-06
- 2020-09-30: Other Liabilities, Fair Value Disclosure $71.00K.
- 2020-06-30: Other Liabilities, Fair Value Disclosure $107.00K.
- 2020-03-31: Other Liabilities, Fair Value Disclosure $77.00K.
- 2019-12-31: Other Liabilities, Fair Value Disclosure $75.00K.
| Period end | Other Liabilities, Fair Value Disclosure |
|---|---|
| 2020-09-30 | $71.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $107.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $77.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $75.00K 10-Q · filed 2020-11-06 |
| 2019-09-30 | $61.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $131.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $147.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $199.00K 10-Q · filed 2019-11-08 |